Vistin Pharma ASA:
Stock exchange announcements

15/4/2025

Vistin Pharma ASA: Invitation to Q1 2025 conference call

13/2/2025

Vistin Pharma ASA: Key information relating to the proposed cash dividend

13/2/2025

Vistin Pharma ASA: Fourth quarter and preliminary 2024 financial results

6/2/2025

Vistin Pharma ASA: Invitation to Q4 2024 conference call

6/11/2024

Ex dividend NOK 0.50 today

31/10/2024

Vistin Pharma ASA: Third quarter and YTD 2024 financial results

24/10/2024

Vistin Pharma ASA: Invitation to Q3 2024 conference call

21/10/2024

Responsibility statement for first half year of 2024

26/9/2024

Vistin Pharma ASA: Mandatory notification of trade

13/9/2024

Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA

23/8/2024

Vistin Pharma ASA: Mandatory notification of trade

23/8/2024

Vistin Pharma ASA: Second quarter and first half 2024 financial results

16/8/2024

Vistin Pharma ASA: Invitation to Q2 2024 conference call

5/6/2024

Ex dividend NOK 0.50 today

23/5/2024

Vistin Pharma ASA: Minutes from the annual general meeting 2024

23/5/2024

Disclosure of voting rights at AGM in Vistin Pharma ASA

30/4/2024

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

24/4/2024

Vistin Pharma ASA: Annual Report 2023

24/4/2024

Vistin Pharma ASA: First quarter 2024 financial results

16/4/2024

Vistin Pharma ASA: Invitation to Q1 2024 conference call

22/3/2024

Vistin Pharma ASA: Mandatory notification of trade

4/3/2024

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)

4/3/2024

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)

16/2/2024

Vistin Pharma ASA: Key information relating to the proposed cash dividend

16/2/2024

Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results

9/2/2024

Vistin Pharma ASA: Invitation to Q4 2023 conference call

23/1/2024

Ex dividend NOK 0.75 today

25/10/2023

Vistin Pharma ASA: Third quarter 2023 financial results

25/10/2023

Vistin Pharma ASA: New CEO appointed

18/10/2023

Vistin Pharma ASA: Invitation to Q3 2023 conference call

18/9/2023

Vistin Pharma ASA: Mandatory notification of trade

26/8/2023

Mandatory notification of trade in Vistin Pharma ASA

23/8/2023

Vistin Pharma ASA: Second quarter and first half 2023 financial results

16/8/2023

Vistin Pharma ASA: Invitation to Q2 2023 conference call

4/7/2023

Management in Vistin Pharma ASA purchases shares

4/7/2023

Vistin Pharma ASA: Results of offer to buy back shares

30/6/2023

Vistin Pharma ASA: Offer to buy back shares

14/6/2023

Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day

31/5/2023

Vistin Pharma ASA: Mandatory notification of trade

30/5/2023

Vistin Pharma ASA: Mandatory notification of trade

22/5/2023

Vistin Pharma ASA: Minutes from the Annual General Meeting 2023

12/5/2023

Disclosure of voting rights at AGM in Vistin Pharma ASA

11/5/2023

Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø

28/4/2023

Notice of Annual General Meeting in Vistin Pharma ASA

27/4/2023

Vistin Pharma ASA: Annual Report for 2022

27/4/2023

Vistin Pharma ASA: First quarter 2023 financial results

20/4/2023

Vistin Pharma ASA: Invitation to Q1 2023 conference call

17/2/2023

Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results

10/2/2023

Vistin Pharma ASA: Invitation to Q4 2022 conference call

9/12/2022

Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft

26/10/2022

Vistin Pharma ASA: Third quarter and YTD 2022 financial results

18/10/2022

Vistin Pharma ASA: Invitation to Q3 2022 conference call

11/10/2022

Vistin Pharma ASA: Invitation to Q2 2022 conference call

19/8/2022

Vistin Pharma ASA: Second quarter and first half 2022 financial results

19/5/2022

Vistin Pharma ASA: Minutes from the annual general meeting 2022

28/4/2022

Vistin Pharma ASA: Notice of Annual General Meeting

27/4/2022

Vistin Pharma ASA: Annual Report for 2021

27/4/2022

Vistin Pharma ASA: First quarter 2022 financial results

20/4/2022

Vistin Pharma ASA: Invitation to Q1 2022 conference call

16/2/2022

New interim CEO

8/2/2022

Vistin Pharma ASA: Invitation to Q4 2021 conference call